MYND Life Sciences Executes a Non-Binding MOU with Tidal Psychedelics
MYND Life Sciences (MYND) entered into an agreement to acquire all the issued and outstanding shares of Tidal Psychedelics, a company with access to a $10M facility for cannabis and mushroom cultivation.